Summary of Product Characteristics
last updated on the eMC:
26/06/2009
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 26/06/2009 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 4.2 - Posology and method of administration
-
Change to section 5.2 - Pharmacokinetic Properties
|
| Date of revision of text on the SPC: 12-Feb-2009 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
The Famvir SmPC has been separated into 4 different SmPCs, one for each strength.
There has been a correction to dosing in Section 4.2.
There has been an update to the patient population information in section 5.2: additional information on subjects with renal impairment, hepatic impairment, the elderly and gender.
|
|
Updated on 19/09/2001 and displayed until 26/06/2009
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
-
SPC Retired pending re-submission
|
|